Traditional Chinese medicine composition for treating esophageal carcinoma

Abstract

The invention relates to a traditional Chinese medicine for treating esophageal carcinoma, particularly relates to a traditional Chinese medicine composition for treating esophageal carcinoma, which is prepared from traditional Chinese medicinal herbs. The traditional Chinese medicine composition is characterized in that the traditional Chinese medicine raw materials for making into active ingredients comprise 20-30g of subprostrate soplhor root, 20-30g of glabrous scrcandra herb, 5-15g of dried human placenta, 5-25g of black nightshade, 5-15g of Indian iphigenia bulb, 5-15g of balloonflower root, and 5-15g of black plum. The traditional Chinese medicinal herbs are compounded to benefit mutually. The traditional Chinese medicine oral decoction provided by the invention has the effects of clearing away heat and toxic materials, relieving sore-throat, diminishing swelling, reducing pathogenic fire, resisting bacteria, diminishing inflammation, expelling pathogenic wind, dredging meridians, promoting blood circulation, dispersing accumulation of pathogen, promoting the dispersing function of lung, and so on. The traditional Chinese medicine composition provided by the invention has combined drug effect of traditional Chinese medicine raw materials, and can be used for treating esophageal carcinoma while enhancing and protecting immunologic function of body and distinctly inhibiting metastasis and diffusion of cancer cells. The traditional Chinese medicine composition has the advantages of small adverse effects, low price, and simple formula.

Description

Technical field [0001] The invention relates to a medicine for treating esophagus cancer, in particular to a traditional Chinese medicine composition for treating esophagus cancer which is made from plant Chinese herbal medicine. Background technique [0002] Esophageal cancer refers to malignant tumors that usually occur in the neck, chest, and abdomen of the esophagus. At present, the early treatment of esophageal cancer is mainly surgery, combined with radiation therapy and chemotherapy. Surgery can remove the cancer, but there is still residual cancer, regional lymph node metastasis, or tumor thrombus in blood vessels, etc., and the probability of recurrence and metastasis is very high. Chemoradiation has many complications and even causes loss of many functions. For patients with advanced tumors, the effect of radiotherapy is not complete. At the same time, for patients with poor physique and older age, continuing radiotherapy can only lead to weaker lives and become ...

AI Technical Summary

Problems solved by technology

There are many complications of radiotherapy and chemotherapy, and even cause loss of many functions. For patients with advanced tumors, the effect of radiotherapy is not complete

At the same time, for patients with poor physical fitness and older age, continuing radiotherapy can only lead to weaker lives and become more critical, accelerating the death of patients

Although chemotherapy has a certain short-term curative effect, it is often accompanied by obvious toxic and side effects, and the remission period is short, and the quality of life is poor, so it cannot significantly prolong the survival of patients